| Name |
Dostinex 0,5 mg tablete |
| Marketing Authorisation Number |
HR-H-951850722 |
| Active Substance |
kabergolin |
| Composition |
jedna tableta sadrži 0,5 mg kabergolina |
| Pharmaceutical Form |
tableta |
| Manufacturer |
Pfizer Italia S.r.l., Ascoli Piceno, Italija |
| Marketing Authorisation Holder |
Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date |
07.04.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/647 |
| Registration Number |
381-12-01/70-20-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
G02CB03 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
